Figure 2From: Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumorsEverolimus 24-h blood concentration-time profiles on day 15 and everolimus blood trough concentration-time profiles during continuous oral dosing for 28 days. Error bars indicate standard deviation.Back to article page